Expression of decay accelerating factor mRNA and complement C3 mRNA in human diseased kidney

Kidney International

Volumn 54, Issue 1, 1998, Pages 120-130

  Abe, Katsushige ^a   Miyazaki, Masanobu ^a   Koji, Takehiko ^b   Furusu, Akira ^b   Ozono, Yoshiyuki ^b   Harada, Takashi ^b   Sakai, Hideto ^b   Nakane, Paul K ^b   Kohno, Shigeru ^b  

^a NAGASAKI UNIVERSITY   (Japan)

^b NONE

Author keywords

Complement C3; DAF; Glomerulonephritis; In situ hybridization; Injury; mRNA; Progression of renal injury

Indexed keywords

COMPLEMENT COMPONENT C3; DECAY ACCELERATING FACTOR; MESSENGER RNA;

ADULT; ARTICLE; CELL SURFACE; CLINICAL ARTICLE; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR APPARATUS; KIDNEY DISEASE; MALE; MESANGIUM CELL; PATIENT CODING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS;

EID: 0031835791     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1998.00961.x     Document Type: Article

References (43)

1. WEST CD: Complement activation in renal disease. Uremia Invest 8:225-235, 1984
2. WYATT RJ, FORRISTAI. CD, WEST S, SUGIMOTO S, CURD JG: Complement profiles in acute post-streptococcal glomerulonephritis. Pediatr Nephrol 2:219-223, 1988
3. COUSER WG: Mechanism of glomerular injury in immune-complex disease. Kidney Int 28:569-583, 1985
4. HINGLAIS N, KAZATCHKINE MD, BHAKDI S, BARIETY J: Immunohistochemical study of the C5b-9 complex of complement in human kidneys. Kidney Int 30:399-410, 1986
5. MIYAMOTO H, YOSHIOKA K TAKEMURA T: Immunohistochemical study of the membrane attack complex of complement in IgA nephropathy. Virchows Archiv A 413:77-86, 1988
6. ALPER CA, JONSON AM, BRITCH AG, MOORE RD: Evidence for the liver as the primary site of synthesis. Science 163:286-288, 1969
7. SACKS SH, ZHOU W, CAMPBELL RD, MARTIN J: C3 and C4 gene expression and interferon-gamma-mediated regulation in human glomerular mesangial cells. Clin Exp Immunol 93:411-417, 1993
8. MONTINARO V, SERRA L, PERISSUTTI S, RANIERI E, TEDESCO F, SCHENA FP: Biosynthesis of C3 by human mesangial cells. Modulation by proinflammatory cytokines. Kidney Int 47:829-836, 1995
9. SACKS SH, ZHOU W, CAMPBELL RD, MARTIN J: Complement C3 gene expression and regulation in human glomerular epithelial cells. Immunology 79:348-354, 1993
10. MOUTABARRIK A, NAKANISHI I, MATSUMOTO M, ZAID D, SEYA T: Human glomerular epithelial cells synthesize and secrete the third component of complement. Nephron 70:55-61, 1995
11. BROOIMANS RA, STEGMANN AP, VAN DORP WT, VAN DER ARK AA, VAN DR WOUDEFJ, VAN Es LA, DAHA MR: Interleukin 2 mediates stimulation of complement C3 biosynthesis in human proximal tubular epithelial cells. J Clin Invest 88:379-384, 1991
12. MIYAZAKI M, ABE K, KOJI T, FURUSU A, OZONO Y, HARADA T, NAKANE PK, ENDOH M, NOMOTO Y, SAKAKI H: Intraglomerular C3 synthesis in human kidney detected by in situ hybridization. J Am Soc Nephrol 7:2428-2433, 1996
13. LACHMAN PJ: The control of homologous lysis. Immunol Today 12:311-314, 1991
14. HOLERS VM, COLL JL, LUBLIN DM, SEYA T, ATKINSON JP: Human C3b and C4h regulatory proteins. A new multi-gene family. Immunol Today 6:188-192, 1989
15. COSIO FG, SEDMAK DD, MAHAN JD, NAHMAN NSJ: Localization of decay accelerating factor in normal and diseased kidneys. Kidney Int 36:100-107, 1989
16. SHIBATA T, COSIO FG, BIRMINGHAM DJ: Complement activation induces the expression of decay accelerating factor on human mesangial cells. J Immunol 11:3901-3908, 1991
17. TOMINO Y, SAKAI H, ENDOH M, KANESHIGE H, NOMOTO Y: Detection of immune complexes in polymorphonuclear leukocytes by double immunofluorescence in patients with IgA nephropathy. Clin Immunol Immunopathol 24:63-71, 1982
18. NOMOTO Y, TOMINO Y, ENDOH M, SUGA T, MIURA T, NOMOTO H, SAKAI H: Modified open renal biopsy: Results in 934 patients. Nephron 45:224-228, 1987
19. MEDOF ME, LUBLIN DM, HOLERS VM, AYERS DJ, GETTY RR, LEYKAM JF, ATKINSON JP, TYKOCINSKI ML: Cloning and characterization of cDNAs encoding the complete sequence of decay-accelerating factor of human complement. Proc Nail Acad Sci USA 84:2007-2011, 1987
20. CARAS IW, DAVITZ MA, RHEE L, WEDDELL G, MARTIN DW, NUSSENZWEIG V: Cloning of decay-accelerating factor suggests novel use of splicing to generate two proteins. Nature 325:545-549, 1987
21. MIYAZAKI M, KOJI T, FURUSU A, ABE K, OZONO Y, HARADA T, NAKA R, SUZUKI D, YAGAME M, ENDOH M, NOMOTO Y, HARA K, NAKANE PK, SAKAI H: In situ hybridization studies of stromelysin and tissue inhibitor of metalloproteinase-1 in IgA nephropathy. Nephrology 1:119-127, 1995
22. NIEMIR ZI, STEIN H, NORONHA IL, KRUGER C, ANDRASSY K, RITZ E, WALDHERR R: PDGF and TGF-β contribute to the natural course of human IgA glomerulonephritis. Kidney Int 48:1530-1541, 1995
23. FURUSU A, MIYAZAKI M, KOJI T, ABE K, OZONO Y, HARADA T, NAKANE PK, HARA K, KOHNO S: Involvement of IL-4 in human glomerulonephritis: An in situ hybridization study of IL-4 mRNA and IL-4 receptor mRNA. J Am Soc Nephrol 8:730-741, 1997
24. PIRANI L, SALINAS-MADRIGUL L, Koss MN: Evaluation of percutaneous renal biopsy, in Kidney Pathology Decennial, edited by SOMMERS SC, New York, Appleton-Century-Crofts, 1975, pp 109-163
25. TANAKA R, SUGIURA H, TATEMATSU A, AGNES F: Internephronheterogeneity of growth factors and sclerosis: Modulation of platelet-derived growth factors by angiotensin II. Kidney Int 47:131-139, 1995
26. OKADA H, KONISHI K, NAKAZATO Y, KANNO Y, SUZUKI H, SAKAGUCHI H, SARUTA T: Interleukin-4 expression in mesangial proliferative glomerulonephritis. Am J Kidney Dis 23:242-246, 1994
27. NICOLIC-WELLER A, BURGE J, FEARSON DT, WELLER PF, AUSTEN KF: Isolation of a human erythrocyte membrane glycoprotein with decay accelerating activity for C3 convertases of the complement system. J Immunol 129:184-189, 1982
28. NICOLIC-WELLER AJ, MARCH CE, ROSEN DB, SPICER, AUSTEN KF: Surface membrane expression by human blood leucocytes and platelets of decay accelerating factor, a regulatory protein of the complement system. Blood 65:1237-1244, 1985
29. KINOSHITA T, MEDOF ME, SILBER R, NUSSENZWEIG V: Distribution of decay accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria. J Exp Med 162:75-92, 1985
30. MCCOY RC, ABRAMOWSKY CR, TISHER CC: IgA nephropathy. Am J Pathol 76:123-144, 1974
31. WINFIELD JB, FAIFERMANN I, KOFFLER D: Avidity of anti-DNA antibodies in serum and IgG glomerular elutes from patients with systemic lupus erythematosus: Association of high avidity anti-native DNA antibody with glomerulonephritis. J Clin Invest 59:90-96, 1987
32. FOURINE GJ: Circulating DNA and lupus nephritis. Kidney Int 33:487-497, 1988
33. NISHIKAGE H, BARANYI L, OKADA H, OKADA N, ISOBE K, NOMURA A, YOSHIDA F, MATSUO S: The role of a complement regulatory protein in rat mesangial glomerulonephritis. J Am Soc Nephrol 6:234-242, 1995
34. HATANAKA Y, YUZAWA Y, NISHIKAWA K, FUKATSU A, OKADA N, OKADA H, MIZUNO M, MATSUO S: Role of a rat membrane inhibitor of complement in anti-basement membrane antibody-induced renal injury. Kidney Int 48:1728-1737, 1995
35. NOMURA A, NISHIKAWA K, YUZAWA Y, OKADA H, OKADA N, MORGEN BP, PIDDLESDEN SJ, NADAI M, HASEGAWA T, MATSUO S: Tubulointerstitial injury in rats by a monoclonal antibody that inhibits function of a membrane inhibitor of complement. J Clin Invest 96:2348-2356, 1995
36. SOMERVILLE C, DENDEREN BV, ADAM B, AMINIAN A, ALLISON J, PEARSE M, D'APLICE A: Expression and function of human CD59 and human CD55 in transgenic mice. Transplant Proc 27:3565-3566, 1995
37. BYRNE GW, MCCURRY KR, KAGAN D, QUINN C, MARTIN MJ, PLATT JL, LOGAN JS: Protection of xenogenic cardiac endothelium from human complement by expression of CD59 or DAF in transgenic mice. Transplantation 60:1149-1156, 1995
38. DENDEREN BJW, PEARSE MJ, KATERELOS M, NOTTLE: MB, DU Z-T, AMINIAN A, ADAM WR, SHENOY-SCARIA A, LUBLIN DM, SHINKEL TA, D'APICE AJF: Expression of functional decay-accelerating factor (CD55) in transgenic mice against human complement-mediated attack. Transplantation 61:582-588, 1996
39. COERS W, Vos JT, VAN DER MEIDE PH, VAN DER HORST ML, HUITEMA S, WEENING JJ: Interferon-gamma (IFN-gamma) and IL-4 expressed during mercury-induced membranous nephropathy are toxic for cultured podocytes. (see comments) Clin Exp Immunol 102:297-307, 1995
40. GASQUE P, MORGAN BP: Complement regulatory protein expression by a human oligodendrocyte cell line: Cytokine regulation and comparison with astrocytes. Immunology 89:338-347, 1996
41. ANDOH A, FUJIYAMA Y, SUMIYOSHI K, SAKUMOTO H, BAMBA T: Interleukin 4 acts as an inducer of decay-accelerating factor gene expression in human intestinal epithelial cells, Gastroenterology 111: 911-918, 1996
42. GERRITSMA JS, GERRITSEN AF, DE LEY M, VAN ES LA, DAHA MR: Interferon-gamma induces biosynthesis of complement components C2, C4 and factor H by human proximal tubular epithelial cells. Cytokine 9:276-283, 1997
43. CLARK EC, NATH KA, HOSTETTER MK, HOSTETTER TH: Role of ammonia in progressive interstitial nephritis. Am J Kidney Dis 17:15-19, 1991